Background Selective androgen receptor modulators (SARMs) increase muscle mass via the androgen receptor. This phase 2A trial investigated the effects of a SARM, GSK2881078, in conjunction with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback